key: cord-0980131-wwnprl0o
authors: DonaireGarcia, Alvaro; Dachepally, Rashmitha; Hanna, William; Latifi, Samir Q.; Agarwal, Hemant S.
title: Inhaled nitric oxide therapy for severe hypoxemia in hyperinflated mechanically ventilated bronchiolitis patient
date: 2022-04-01
journal: Respir Med Case Rep
DOI: 10.1016/j.rmcr.2022.101643
sha: cdfe6dc39c93a78e2c11597c2773c8e25211e2f4
doc_id: 980131
cord_uid: wwnprl0o

Management of hospitalized bronchiolitis patients comprises supportive care including non-invasive and invasive mechanical ventilation. Inhaled nitric oxide (iNO) therapy has been used in bronchiolitis patients to manage pulmonary hypertension, acute respiratory distress syndrome, bronchoconstriction or inflammation. We report the role of iNO in management of severe hypoxemia in a 7-month-old mechanically ventilated bronchiolitis patient on 100% oxygen and high ventilator settings who had hyperinflation on chest x-ray, and diffuse bronchospasm on clinical assessment. We believe iNO improved hypoxemia in our patient by optimizing the ventilation/perfusion mismatch, decreasing dead space ventilation and relieving elevated pulmonary vascular resistance associated with alveolar overdistention. Inhaled nitric oxide therapy for severe hypoxemia in hyperinflated mechanically ventilated bronchiolitis patient.

Acute bronchiolitis is a common clinical condition affecting infants and young children, with lack of specific treatment besides supportive care [1] . 2%-3% of bronchiolitis patients are hospitalized in the USA and 10%-15% of these patients require additional noninvasive or invasive mechanical ventilatory support [2, 3] . Inhaled nitric oxide (iNO) therapy has demonstrated a beneficial role in bronchiolitis patients in the management of pulmonary hypertension/elevated pulmonary vascular resistance [4, 5] , pediatric acute respiratory distress syndrome (PARDS) [6] [7] [8] , bronchoconstriction [7] , and inflammation [9] [10] [11] . We report a role of iNO therapy in the treatment of severe hypoxemia in a hyperinflated mechanically ventilated bronchiolitis patient in the absence of pulmonary hypertension. Addition of iNO therapy to conventional mechanical ventilation ameliorated further escalation of care in our patient.

A written informed consent was obtained from the parents of the patient for publication of this case report. Institutional IRB waivers approval for the production and publication of case reports. A 7-month-old female infant weighing 6.1 kg, an ex-34 week preemie with bronchopulmonary dysplasia on 1/4th liter/min nasal cannula oxygen therapy at baseline, was hospitalized for the management of corona (non-SARS-CoV-2) virus bronchiolitis. She had moderate respiratory distress, diffuse wheezing on auscultation, and hyperinflated lung fields on her chest x-ray. She was initiated on 2 L/kg of high flow nasal cannula support, continuous albuterol nebulization, and methylprednisolone. She was intubated within 12 hours of admission for persistent respiratory distress and oxygen desaturation to 84-86%. She was placed on a pressure control mode of ventilation and bronchodilator (terbutaline and ketamine) and neuromuscular (cis-atracurium) infusions were added to her management. She continued to demonstrate hypoxemia (oxygen saturations of 82-84%) and hypercarbia (venous blood gas Her chest x-ray continued to reveal hyperinflation with patchy atelectasis in both lung fields. Her ventilator settings revealed a plateau pressure (PPLAT): 28 cm H 2 O, auto-PEEP: 11cm H 2 O, and a concave expiratory curve on tidal breathing flow volume loops (Table 1) . She was initiated on iNO therapy at 20 ppm empirically for the management of persistent oxygen desaturation of 85-86% and oxygenation index (OI) of 34 on significant ventilator settings and 100% oxygen therapy. Addition of iNO therapy resulted in significant improvement in her oxygenation and dead space ventilation without much change in her lung compliance or airway resistance (Table 1) . A transthoracic echocardiogram within the next 4 hours revealed good biventricular function, without any evidence of pulmonary hypertension. Her echocardiogram in the previous month had revealed normal right ventricle size and function, less than half systemic pulmonary artery pressure and her chest computerized tomography study had revealed normal pulmonary parenchymal architecture. She was weaned off iNO therapy in 3 days, extubated after 6 days, and discharged home 2 weeks later.

Bronchiolitis is a disease process characterized by extensive inflammation and edema of the airways, increased mucus production, and necrosis of airway epithelial cells that result in extensive bronchiolar obstruction and lung hyperinflation [12] . Pulmonary function tests of intubated and mechanically ventilated bronchiolitis patients reveal increased functional residual capacity, increased pulmonary resistance, and decreased pulmonary compliance as also seen in our patient [13, 14] . A widespread ventilation perfusion (VA/Q) mismatch with lack of association between radiological examination and lung perfusion scintigraphy has been reported in bronchiolitis patients [15] . Hypoxemia is associated with an increase in dead space/tidal volume (Vd/Vt) ratio in mechanically ventilated bronchiolitis patients secondary to VA/Q mismatch and alveolar overdistention [16] . In heterogeneous obstruction of the airways, as seen in bronchiolitis patients, ventilation is preferentially distributed to units that impose less airflow resistance and have faster time constants [17] . As a result, when iNO was added to the ventilator circuit in our patient, it was preferentially delivered to the well-ventilated alveoli with faster time constants. We believe that the selective vasodilator action of iNO in these well-ventilated alveoli facilitated the redistribution of pulmonary blood flow, improved VA/Q mismatch, and associated changes in alveolar gas exchange and hypoxemia in our patient [18, 19] . In addition, iNO may have also relieved some of the increase in pulmonary vascular resistance due to the physical compression of the microvasculature seen with alveolar overdistenstion [20, 21] . It is less likely that iNO therapy in our patient had any role on pulmonary hypertension, PARDS, bronchoconstriction, or inflammation as previously reported [4] [5] [6] [7] [8] [9] [10] [11] . Echocardiogram in our patient prior and at the time of illness did not reveal pulmonary hypertension. Previous reports of iNO therapy in PARDS and pediatric acute hypoxemic respiratory failure patients have demonstrated an improvement in hypoxemia even in the absence of pulmonary hypertension [22, 23] . Our patient did not have any new infiltrate on chest imaging to qualify for PARDS [24] . iNO therapy did not have bronchodilatory affect as there were no changes in auto-PEEP or airway resistance after iNO initiation. Table 1 Mechanical ventilation and gas exchange parameters before and after initiation of inhaled nitric oxide therapy. The rapid response to iNO therapy precluded its role as an anti-inflammatory and antiviral agent. Limitation of our report includes lack of formal pulmonary function testing to demonstrate abnormalities in functional residual capacity and pulmonary compliance and lack of lung perfusion scan to demonstrate VA/Q mismatch. However, we evaluated bed-side pulmonary compliance, airway resistance, and end-tidal CO 2 measurements and performed serial chest x-rays to demonstrate hyperinflation with patchy atelectasis.

In summary, it may seem reasonable to consider the use of iNO as an off-label therapy in hyperinflated mechanically ventilated bronchiolitis patients who present with severe hypoxemia. It may not directly affect the bronchiolitis disease process, however, it may improve hypoxemia by optimizing the VA/Q mismatch and relieving the elevated pulmonary vascular resistance secondary to alveolar overdistention. 

None.

American Academy of Pediatrics: clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis

Increased use of noninvasive ventilation associated with decreased use of invasive devices in children with bronchiolitis

Role of ventilation in RSV disease: CPAP, ventilation, HFO, ECMO, Pediatr

Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure

Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness

Treatment of respiratory failure with inhaled nitric oxide and high-frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia

Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia

Successful use of inhaled nitric oxide for severe hypoxemia in an infant with acute exacerbation of bronchiolitis due to sepsis

Inhaled nitric oxide therapy in acute bronchiolitis: a multicenter randomized clinical trial

Nitric oxide inhalations in bronchiolitis. A pilot, randomized, double-blinded, controlled trial

Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing

Kendig and Chernick's Disorders of the Respiratory Tract in Children

The disturbances of ventilation in acute bronchiolitis

Lung function after acute bronchiolitis

Pulmonary blood flow distribution in acute viral bronchiolitis

Relationship between physiologic deadspace/tidal volume ratio and gas exchange in infants with acute bronchiolitis on invasive mechanical ventilation

Frequency dependence of compliance as a test for obstruction in the small airways

Nitric oxide inhalation during exercise in chronic obstructive lung disease

Nitric oxide inhalation increases alveolar gas exchange by decreasing dead space volume

Distribution of blood flow in isolated lung: relation to vascular and alveolar pressures

Measurements of capillary dimensions and blood volume in rapidly frozen lungs

Association of response to inhaled nitric oxide and duration of mechanical ventilation in pediatric acute respiratory distress syndrome

Inhaled nitric oxide use in pediatric hypoxemic respiratory failure

Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference